Astellas' Novel Anti-fungal Wins FDA Panel Support

January 23, 2015 5:04 PM

4 0

Astellas' Novel Anti-fungal Wins FDA Panel Support

Committee favors Cresemba for aspergillosis.

SILVER SPRING, Md. -- Astellas' novel drug, isavuconazonium (Cresemba) for treatment of invasive aspergillosis won the unanimous endorsement of an FDA advisory committee.

Read more

To category page

Loading...